Entertainment Industry FoundationEIF
About EIF | EIF National Initiatives | EIF Events | Press | donors | Donate | Contact Us stars
Description











Make a Donation!






MEPHISTO'S HOPE SHOE DEBUTS IN STORES IN FEBRUARY
Sales from the Hope shoe to benefit Entertainment Industry Foundation's Women's Cancer Program

Franklin, Tenn., (February, 2007) - Mephisto's limited edition HOPE shoe will debut in retailers across the U.S. in February. With $10 from every purchase directed to the Women's Cancer Programs of the Entertainment Industry Foundation, the HOPE shoe marks the first in a series of cause-related product launches from Mephisto.

EIF's Women's Cancer Programs are committed to raise awareness about the importance of early detection of breast cancer and provide funds to advance research on treatment and early detection methods. EIF's funding strategy is results-driven, bringing together some of the very best scientists and institutions in the country to collaborate on groundbreaking research projects to fast-track the development of better prevention methods and improved therapies for treatment of breast cancer.

"The Entertainment Industry Foundation is so grateful for Mephisto's support in the crusade to fight breast cancer," said Lisa Paulsen, President and CEO of the Entertainment Industry Foundation. "The HOPE Shoe program will help garner attention and support for groundbreaking research focused on better ways to detect breast cancer early - when survival rates are high."

The pink HOPE shoe is a special edition product from the Allrounder by Mephisto NIRO collection, adorned with an embroidered breast cancer ribbon. The most popular line from the brand, the NIRO is a Mary Jane-style, light hiking shoe featuring advanced technical and comfort features synonymous with the Mephisto brand.

Features specific to the HOPE NIRO include:

  • Active suspension, innovative, patented shock-absorber system
  • Removable cushioned anatomical footbed
  • Multi-functional grip profile abrasion-resistant outsole
  • Dynamic control with bi-lateral stabilizers between the heel and forefoot
  • Hydrosoft, water-repellent genuine breathable leather
  • Velcro straps on the ankle and heel

"What is most exciting about this endeavour is the opportunity to partner with our retailers and together play an active role in the fight against breast cancer," said Ron Martin, President/CEO of Mephisto USA. " We are proud to introduce the HOPE shoe in February as this product marks Mephisto's commitment to contribute to a worthy cause."

The HOPE shoe is available in sizes 5.5 to 11 with a suggested retail of $165.

Allrounder by Mephisto is a lifestyle brand featuring a variety of styles for all types of leisure and outdoor activities. It embodies healthy lifestyle choices for active individuals wanting to get the best out of life. Every Allrounder by Mephisto shoe features an Active Suspension System that provides shock absorption; Dynamic Control for optimal stability; and a multifunctional rubber Grip Profile sole that is abrasion and slip resistant. For more information on Allrounder by Mephisto, visit www.allrounder.com.

About MEPHISTO
With worldwide headquarters in Sarrebourg, France, Mephisto was founded over 40 years ago by Martin Michaeli. Mephisto has a loyal following and strong international reputation for comfort and quality. Its unequaled handcrafted footwear styles include sandals, boots, clogs, dress and classic walkers as well as the ergonomic brand, Mobils. In recent years, the company has also introduced a more athletically-inspired brand, Allrounder by Mephisto.

About EIF
The Entertainment Industry Foundation, as a leading charity of the entertainment industry, has distributed hundreds of millions of dollars - and provided countless hours - to support charitable initiatives that address critical health, education and social issues.

Contact
Mike Alday, Angie Alsup
Alday Communications
615-791-1535 ext. 24
mike@aldaycommunications.com
angie@aldaycommunications.com

----

High resolution images are available.



©2002-2007 Entertainment Industry Foundation
Terms of Use | Privacy Policy